Literature DB >> 24935529

Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren׳s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study.

Francesco Carubbi1, Alessia Alunno2, Paola Cipriani3, Paola Di Benedetto3, Piero Ruscitti3, Onorina Berardicurti3, Elena Bartoloni2, Onelia Bistoni2, Sara Caterbi2, Francesco Ciccia4, Giovanni Triolo4, Roberto Gerli2, Roberto Giacomelli3.   

Abstract

OBJECTIVES: Several histological scoring systems, including the focus score, performed in minor salivary glands (MSGs) by hematoxylin-eosin (H&E) staining, have been employed in clinical practice to assess the inflammatory infiltrate and provide the diagnosis of primary Sjo¨gren׳s syndrome (pSS). Aims of this study were to integrate different scoring systems and identify potential differences in the molecular profile of lymphoid cytokines related to germinal center (GC) formation and clinical subsets in pSS.
METHODS: Overall, 104 pSS patients and 40 subjects with sicca non-pSS were retrospectively evaluated. MSG biopsies were evaluated by H&E and immunofluorescence to assess histological pattern, Chisholm and Mason grading system, Tarpley score, a grading for the severity of inflammatory infiltrate, T-/B-cell segregation, and the presence of GC. MSGs from 50 pSS patients and 30 sicca non-pSS patients were processed by real-time PCR to assess LTα, LTβ, BAFF, CXCR4, CXCL12, CXCR5, CXCL13, CCR7, CCL19, and CCL21.
RESULTS: GCs presence was associated with anti-Ro/SSA and anti-La/SSB antibodies, hypergammaglobulinemia, salivary gland swelling, higher Tarpley score and focus score, and extraglandular involvement but, at multivariate analysis, only extraglandular involvement was independently associated to GC. pSS patients displayed higher level of all cytokines compared to those with sicca symptoms. GC(+) pSS patients displayed higher level of all cytokines compared to those GC(-).
CONCLUSIONS: Our study demonstrates that different histopathological patterns, including GC presence, reflect different cytokine expression and different clinical subsets. We believe that the combined immunofluorescence/molecular approach in MSGs would help to tailor diagnostic and therapeutic approach for different subsets of pSS patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BAFF; CCL19; CCL21; CCR7; CXCL12; CXCL13; CXCR4; CXCR5; Germinal center; LTα; LTβ; Minor salivary glands; Sjo¨gren׳s syndrome

Mesh:

Substances:

Year:  2014        PMID: 24935529     DOI: 10.1016/j.semarthrit.2014.05.015

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  23 in total

Review 1.  Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers.

Authors:  Andreas V Goules; Athanasios G Tzioufas
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

2.  Incidence and Mortality of Physician-Diagnosed Primary Sjögren Syndrome: Time Trends Over a 40-Year Period in a Population-Based US Cohort.

Authors:  Gabriel Maciel; Cynthia S Crowson; Eric L Matteson; Divi Cornec
Journal:  Mayo Clin Proc       Date:  2017-05       Impact factor: 7.616

Review 3.  B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

Authors:  Mathieu Uzzan; Jean-Frederic Colombel; Andrea Cerutti; Xavier Treton; Saurabh Mehandru
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

4.  Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.

Authors:  L A Aqrawi; M Ivanchenko; A Björk; J I Ramírez Sepúlveda; J Imgenberg-Kreuz; M Kvarnström; P Haselmayer; J L Jensen; G Nordmark; K Chemin; K Skarstein; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2018-03-24       Impact factor: 4.330

5.  Fatty infiltration of the minor salivary glands is a selective feature of aging but not Sjögren's syndrome.

Authors:  Kerry M Leehan; Nathan P Pezant; Astrid Rasmussen; Kiely Grundahl; Jacen S Moore; Lida Radfar; David M Lewis; Donald U Stone; Christopher J Lessard; Nelson L Rhodus; Barbara M Segal; C Erick Kaufman; R Hal Scofield; Kathy L Sivils; Courtney Montgomery; A Darise Farris
Journal:  Autoimmunity       Date:  2017-10-08       Impact factor: 2.815

Review 6.  Diagnostic performance of serology against histologic assessment to diagnose Sjogren's syndrome: a systematic review.

Authors:  Luiz Claudio Viegas-Costa; Reid Friesen; Carlos Flores-Mir; Timothy McGaw
Journal:  Clin Rheumatol       Date:  2021-06-17       Impact factor: 2.980

7.  Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren's syndrome.

Authors:  Chiara Baldini; Nicoletta Luciano; Gaia Tarantini; Rachele Pascale; Francesca Sernissi; Marta Mosca; Davide Caramella; Stefano Bombardieri
Journal:  Arthritis Res Ther       Date:  2015-05-28       Impact factor: 5.156

8.  Telocytes in minor salivary glands of primary Sjögren's syndrome: association with the extent of inflammation and ectopic lymphoid neogenesis.

Authors:  Alessia Alunno; Lidia Ibba-Manneschi; Onelia Bistoni; Irene Rosa; Sara Caterbi; Roberto Gerli; Mirko Manetti
Journal:  J Cell Mol Med       Date:  2015-03-06       Impact factor: 5.310

9.  Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis?

Authors:  Alessia Alunno; Valeria Caneparo; Francesco Carubbi; Onelia Bistoni; Sara Caterbi; Elena Bartoloni; Roberto Giacomelli; Marisa Gariglio; Santo Landolfo; Roberto Gerli
Journal:  Arthritis Res Ther       Date:  2015-08-14       Impact factor: 5.156

10.  B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedure.

Authors:  Sebastian Costa; Sacha Schutz; Divi Cornec; Arnaud Uguen; Isabelle Quintin-Roué; Agnès Lesourd; Jean-Marie Berthelot; Eric Hachulla; Pierre-Yves Hatron; Vincent Goeb; Olivier Vittecoq; Jacques Olivier Pers; Pascale Marcorelles; Alain Saraux; Valérie Devauchelle-Pensec
Journal:  Arthritis Res Ther       Date:  2016-01-20       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.